1.8114
-0.0786
(-4.16%)
At close: January 10 at 4:00:00 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
1,850.0000
6,845.0000
3,960.0000
3,245.0000
Total Liabilities Net Minority Interest
1,196.0000
3,579.0000
509.0000
886.0000
Total Equity Gross Minority Interest
654.0000
3,266.0000
3,451.0000
2,359.0000
Total Capitalization
1,582.0000
3,905.0000
3,451.0000
2,359.0000
Common Stock Equity
1,582.0000
3,905.0000
3,451.0000
2,359.0000
Net Tangible Assets
1,582.0000
3,905.0000
3,451.0000
2,359.0000
Working Capital
654.0000
3,266.0000
3,451.0000
2,359.0000
Invested Capital
1,582.0000
3,905.0000
3,451.0000
2,359.0000
Tangible Book Value
1,582.0000
3,905.0000
3,451.0000
2,359.0000
Share Issued
341.3010
63.6510
18.7460
14.8860
Ordinary Shares Number
341.3010
63.6510
18.7460
14.8860
12/31/2020 - 6/27/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
FBIO Fortress Biotech, Inc.
2.0300
-2.40%
DRMA Dermata Therapeutics, Inc.
1.2000
-4.76%
AKTX Akari Therapeutics, Plc
1.2150
-5.08%
CELZ Creative Medical Technology Holdings, Inc.
2.1700
-9.96%
FBIOP Fortress Biotech, Inc.
6.97
+5.61%
KZR Kezar Life Sciences, Inc.
6.51
-1.06%
BNTC Benitec Biopharma Inc.
11.00
-0.54%
GLYC GlycoMimetics, Inc.
0.2650
-4.26%
CKPT Checkpoint Therapeutics, Inc.
3.1600
-1.56%
MBIO Mustang Bio, Inc.
0.2566
+15.38%